ClinVar Miner

Submissions for variant NM_000487.6(ARSA):c.656G>A (p.Arg219His)

gnomAD frequency: 0.00021  dbSNP: rs148403406
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000177070 SCV000228889 uncertain significance not provided 2015-05-26 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002222426 SCV002500479 uncertain significance not specified 2023-12-07 criteria provided, single submitter clinical testing Variant summary: ARSA c.656G>A (p.Arg219His) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.6e-05 in 250704 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in ARSA causing Metachromatic Leukodystrophy (5.6e-05 vs 0.0028), allowing no conclusion about variant significance. c.656G>A has been reported in the literature as a complex allele in cis with c.1108C>T (p.Arg370Trp) (also known as c.1114C>T, p.Arg372Trp) in at-least one individual with Metachromatic Leukodystrophy (MLD) who harbored c.1108C>T in isolation on the other allele (Grossi_2008). This supports the cis orientation of this variant. To our knowledge, this variant has not been reported in isolation in individuals affected with MLD. Therefore, these report(s) do not provide unequivocal conclusions about association of the variant with Metachromatic Leukodystrophy. Of note, c.1108C>T is well reported as a pathogenic/likely pathogenic ARSA variant associated with MLD. At least one publication reports experimental evidence evaluating an impact of this variant in isolation on protein function (example, Grossi_2008). The most pronounced variant effect results in 15.6% of normal ARSA enzyme activity in-vitro in transfected COS-7 cells. The following publications has been ascertained in the context of this evaluation (PMID: 26462614, 18693274). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
Invitae RCV002517709 SCV003276257 uncertain significance Metachromatic leukodystrophy 2022-08-09 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 219 of the ARSA protein (p.Arg219His). This variant is present in population databases (rs148403406, gnomAD 0.07%). This missense change has been observed in individual(s) with metachromatic leukodystrophy (PMID: 18693274). This variant is also known as p.R217H. ClinVar contains an entry for this variant (Variation ID: 196276). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Experimental studies have shown that this missense change affects ARSA function (PMID: 18693274). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.